Mucosan Childrens Multi-Symptom Grape
- Manufacturer
- Menper Distributors, Inc.
- Effective date
- 2026-01-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:31:57
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients (in each 5 mL, 1 teaspoon) Purposes
Dextromethorphan HBr, 5 mg...............................Cough suppressant
Guaifenesin, 50 mg...............................................Expectorant
Phenylephrine HCl, 2.5 mg...................................Nasal decongestant
OTC - PURPOSE SECTION
Purpose
Cough suppressant
Expectorant
Nasal decongestant
INDICATIONS & USAGE SECTION
Uses
- helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes
- temporarily relieves these symptoms occurring with a cold:
- nasal congestion
- cough due to minor throat and bronchial irritation
WARNINGS SECTION
Do not usein a child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 week after stopping the MAOI drug. If you do not know if your child's prescritpion drug contains an MAOI, ask a doctor or pharmacist before taking this product.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if the child has
- heart disease
- diabetes
- high blood pressure
- thyroid disease
- cough that lasts or is chronic such as occurs with asthma
- cough that occurs with too much phlegm (mucus)
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if the child istaking any other oral nasal decongestant or stimulant.
OVERDOSAGE SECTION
Do not exceed recommended dosage.
OTC - STOP USE SECTION
Stop use and ask a doctor if
- nervousness, dizziness, or sleeplessness occurs
- symptoms do not get better within 7 days or are accompanied by fever
- cough lasts more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache.
These could be signs of a serious condition.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.
DOSAGE & ADMINISTRATION SECTION
Directions
- do not take more than 6 doses in any 24 hour period
- measure only with dosing cup provided
- keep dosing cup with product
- TSP=teaspoon
| age | dose |
| children 6 to under 12 years | 2 teaspoons (10mL) every 4 hours |
| children 4 to under 6 years | 1 teaspoon (5mL) every 4 hours |
| children under 4 years | do not use |
OTHER SAFETY INFORMATION
Other information
- each teaspoon (5mL) contains:sodium 3 mg
- store at 15-30°C (59-86°F). Do not refrigerate.
INACTIVE INGREDIENT SECTION
Inactive ingredients
citric acid, FD&C blue #1, FD&C red #40, flavor, glycerin, propylene glycol, purified water, sodium benzoate, sorbitol, sucralose, xanthan gum.
OTC - QUESTIONS SECTION
Questions or comments?
1-800-560-5223 Monday to Friday 9am-4pm, Eastern Time
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1370205 | dextromethorphan HBr 5 MG / guaiFENesin 50 MG / phenylephrine HCl 2.5 MG in 5 mL Oral Solution | PSN | 2 |
| 1370205 | dextromethorphan hydrobromide 1 MG/ML / guaifenesin 10 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution | SCD | 2 |
| 1370205 | dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG per 10 ML Oral Solution | SY | 2 |
| 1370205 | dextromethorphan hydrobromide 5 MG / guaifenesin 50 MG / phenylephrine hydrochloride 2.5 MG per 5 ML Oral Solution | SY | 2 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53145-691-04 | Mucosan Childrens Multi-Symptom Grape | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 | 2 | |
| 53145-691-04 | Mucosan Childrens Multi-Symptom Grape | 1 in 1 CARTON | LIQUID | 1 | 2 |
Products#
Every source-derived product name is available through these pages.
- Mucosan Childrens Multi-Symptom Grape
- DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE
- CITRIC ACID
- XANTHAN GUM
- SODIUM BENZOATE
- FD&C RED NO. 40
- WATER
- FD&C BLUE NO. 1
- GLYCERIN
- SORBITOL
- SUCRALOSE
- PROPYLENE GLYCOL
- GUAIFENESIN
- DEXTROMETHORPHAN HYDROBROMIDE
- DEXTROMETHORPHAN
- PHENYLEPHRINE HYDROCHLORIDE
- PHENYLEPHRINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53145-691 | 53145-691-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CITRIC ACID | 2968PHW8QP | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| FD&C RED NO. 40 | WZB9127XOA | IACT |
| WATER | 059QF0KO0R | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| SORBITOL | 506T60A25R | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| GUAIFENESIN | 495W7451VQ | ACTIB |
| DEXTROMETHORPHAN HYDROBROMIDE | 9D2RTI9KYH | ACTIB |
| PHENYLEPHRINE HYDROCHLORIDE | 04JA59TNSJ | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucosan Childrens Multi-Symptom Grape | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Menper Distributors, Inc. | 266c8cce-cdf9-557d-e063-6394a90a9bc3 | 2026-01-08 | Warnings | 53145-691-04 53145-691 53145069104 47e28df8-bf97-427e-e063-6294a90abe62 266c8cce-cdf9-557d-e063-6394a90a9bc3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

